Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06692231Not ApplicableNot Yet Recruiting

Impact of Hospital Pharmacist Intervention on Medication Management in Dialysis Patients

Role: lead

NCT05545267Unknown

Monitoring of Dialysis Vascular Accesses During Angioplasty Under Echodoppler

Role: lead

NCT04102527Unknown

Evaluation of the Impact of Transit Troubles in Patients Undergoing Peritoneal Dialysis

Role: lead

NCT03927300Completed

Telemonitoring Impact by the ApTelecare Software in Dialysis Patient

Role: collaborator

NCT01114789Not ApplicableUnknown

Impact on the Proteolysis of Obesity in Dialysis

Role: collaborator

All 5 trials loaded